Scanning certainly makes sense. What REGN ultimately might need is a trial with "as-needed" Lucentis vs. "as-needed" trap. I suspect that the trap would require significantly fewer injections over a multi-year period.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.